Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Danlou Tablets to Prevent Left Ventricular Remodeling After Myocardial Infarction: A Double-blind, Randomized, Placebo Controlled, Pilot Study

NCT02675322 is registered in ClinicalTrials.gov with shuai Mao as lead sponsor.

NCT NCT02675322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02675322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Danlou Tablets to Prevent Left Ventricular Remodeling After Myocardial Infarction: A Double-blind, Randomized, Placebo Controlled, Pilot Study
Lead sponsor
shuai Mao
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2012
Completion date
December 31, 2015
Enrollment
82 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction, left ventricular remodeling